The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Weak Interactions Govern the Viscosity of Concentrated Antibody Solutions: High-Throughput Analysis Using the Diffusion Interaction Parameter
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Zeta potential in colloid science. Principles and applications
Vold, M. J. (1982) · Journal of Colloid and Interface Science · doi:10.1016/0021-9797(82)90296-x · Cited by 2,330
Zeta potential in colloid science : principles and applications
Hunter, R. J. (1981) · Cited by 1,942
Measurement and interpretation of electrokinetic phenomena
Delgado, A. V., González-Caballero, F., Hunter, R. J., Koopal, L. K., & Lyklema, J. (2007) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.12.075 · Cited by 1,335
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Self-citationChallenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Self-citationLiu, J., Nguyen, M. D. H., Andya, J. D., & Shire, S. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20347 · Cited by 436
Self-citationKanai, S., Liu, J., Patapoff, T. W., & Shire, S. J. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21322 · Cited by 304
Self-citation
Cited by
Physicochemical Stability of Monoclonal Antibodies: A Review
Le Basle, Y., Chennell, P., Tokhadze, N., Astier, A., & Sautou, V. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.08.009 · Cited by 429
Lin, Y., Currie, S. L., & Rosen, M. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.800466 · Cited by 412
Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites
Yoshizawa, T., Ali, R., Jiou, J., Fung, H. Y. J., Burke, K. A., Kim, S. J., Lin, Y., Peeples, W. B., Saltzberg, D., Soniat, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.003 · Cited by 329
Protein aggregation and its impact on product quality
Roberts, C. J. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.08.001 · Cited by 316
Structure, heterogeneity and developability assessment of therapeutic antibodies
Xu, Y., Wang, D., Mason, B., Rossomando, T., Li, N., Liu, D., Cheung, J. K., Xu, W., Raghava, S., Katiyar, A., et al. (2019) · mAbs · doi:10.1080/19420862.2018.1553476 · Cited by 264
Sharma, V. K., Patapoff, T. W., Kabakoff, B., Pai, S., Hilario, E., Zhang, B., Li, C., Borisov, O., Kelley, R. F., Chorny, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421779112 · Cited by 254
Developability Assessment During the Selection of Novel Therapeutic Antibodies
Jarasch, A., Koll, H., Regula, J. T., Bader, M., Papadimitriou, A., & Kettenberger, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24430 · Cited by 242
Developments and Challenges for mAb-Based Therapeutics
Goswami, S., Wang, W., Arakawa, T., & Ohtake, S. (2013) · Antibodies · doi:10.3390/antib2030452 · Cited by 144
Lai, P.-K., Fernando, A., Cloutier, T. K., Kingsbury, J. S., Gokarn, Y., Halloran, K. T., Calero-Rubio, C., & Trout, B. L. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.12.014 · Cited by 45
Arsiwala, A., Bhatt, R., van Niekerk, L., Quintero-Cadena, P., Ao, X., Rosenbaum, A., Bhatt, A., Smith, A., Yang, Y., Anderson, K., et al. (2025) · mAbs · doi:10.1080/19420862.2025.2593055 · Cited by 16
Metadata
- Authors
- Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R.
- Venue
- Biophysical Journal
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 103
- Issue
- 1
- Pages
- 69-78
- ISSN
- 0006-3495 (ISSN-L)
- OpenAlex
- W2036879738
- Cited by
- 340
- References
- 30
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.